NO20082989L - Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet - Google Patents

Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet

Info

Publication number
NO20082989L
NO20082989L NO20082989A NO20082989A NO20082989L NO 20082989 L NO20082989 L NO 20082989L NO 20082989 A NO20082989 A NO 20082989A NO 20082989 A NO20082989 A NO 20082989A NO 20082989 L NO20082989 L NO 20082989L
Authority
NO
Norway
Prior art keywords
amino acids
gamma
affinity
alpha
preparation
Prior art date
Application number
NO20082989A
Other languages
English (en)
Norwegian (no)
Inventor
Margaret Claire Evans
Lloyd Charles Franklin
Lorraine Michelle Murtagh
Thomas Norman Nanninga
Bruce Allen Pearlman
James Edward Saenz
Niamh Josephine Willis
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20082989L publication Critical patent/NO20082989L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/32Preparation of optical isomers by stereospecific synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/002Nitriles (-CN)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/005Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20082989A 2005-12-21 2008-07-02 Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet NO20082989L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75283905P 2005-12-21 2005-12-21
PCT/IB2006/003656 WO2007072159A1 (fr) 2005-12-21 2006-12-11 Preparation d’acides gamma-amines ayant une affinite pour la proteine alpha-2-delta

Publications (1)

Publication Number Publication Date
NO20082989L true NO20082989L (no) 2008-09-19

Family

ID=37903526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082989A NO20082989L (no) 2005-12-21 2008-07-02 Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet

Country Status (28)

Country Link
US (2) US20070141684A1 (fr)
EP (2) EP2017259A3 (fr)
JP (1) JP2009520492A (fr)
KR (1) KR20080068932A (fr)
CN (1) CN101341117A (fr)
AP (1) AP2008004485A0 (fr)
AR (1) AR058559A1 (fr)
AU (1) AU2006327872A1 (fr)
BR (1) BRPI0620467A2 (fr)
CA (1) CA2633358A1 (fr)
CR (1) CR10080A (fr)
DO (1) DOP2006000286A (fr)
EA (1) EA200801393A1 (fr)
EC (1) ECSP088551A (fr)
GT (1) GT200600524A (fr)
IL (1) IL191840A0 (fr)
MA (1) MA30139B1 (fr)
ME (1) ME00005B (fr)
NL (1) NL2000374C2 (fr)
NO (1) NO20082989L (fr)
NZ (1) NZ568971A (fr)
PE (1) PE20071169A1 (fr)
RS (1) RS20080279A (fr)
TN (1) TNSN08272A1 (fr)
TW (1) TW200736201A (fr)
UY (1) UY30031A1 (fr)
WO (1) WO2007072159A1 (fr)
ZA (1) ZA200804780B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2724828C (fr) * 2008-05-21 2016-01-12 Sandoz Ag Procede pour l'hydrolyse enzymatique stereoselective d'un ester d'acide 5-methyl-3-nitromethyl-hexanoique
CN103003264B (zh) 2010-05-21 2014-08-06 切米利亚股份公司 嘧啶衍生物
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
EP2688883B1 (fr) 2011-03-24 2016-05-18 Noviga Research AB Dérivés de pyrimidine
CN102249833B (zh) * 2011-05-27 2013-12-11 中国科学院化学研究所 一种制备手性γ-氨基酸及其衍生物的方法
WO2017155025A1 (fr) * 2016-03-10 2017-09-14 第一三共株式会社 Procédé de production de dérivés optiquement actifs de l'acide valérique par résolution optique au moyen d'une enzyme
CN108192932B (zh) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 一种手性醇的酶催化制备方法
CN112877219A (zh) * 2021-01-29 2021-06-01 江西科技师范大学 一种高浓度胆固醇培养基及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (fr) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Liberation amelioree d'agents medicamenteux actifs par un enrobage de chewing-gum
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
GEP20074142B (en) 1999-06-10 2007-07-10 Warner Lambert Co Mono- and Disubstituted 3-Propyl Gamma-Aminobutyric Acids
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
JP2006513257A (ja) 2002-12-13 2006-04-20 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 線維筋痛症および他の障害を処置するためのプレガバリン誘導体
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)

Also Published As

Publication number Publication date
RS20080279A (en) 2009-07-15
MEP0708A (xx) 2010-02-10
NL2000374A1 (nl) 2007-06-25
CN101341117A (zh) 2009-01-07
EP2017259A2 (fr) 2009-01-21
BRPI0620467A2 (pt) 2011-11-16
US20070141684A1 (en) 2007-06-21
TW200736201A (en) 2007-10-01
AU2006327872A1 (en) 2007-06-28
NL2000374C2 (nl) 2010-02-09
WO2007072159A1 (fr) 2007-06-28
MA30139B1 (fr) 2009-01-02
IL191840A0 (en) 2008-12-29
CA2633358A1 (fr) 2007-06-28
GT200600524A (es) 2007-12-03
KR20080068932A (ko) 2008-07-24
PE20071169A1 (es) 2007-11-30
AP2008004485A0 (en) 2008-06-30
EP2017259A3 (fr) 2011-04-13
EA200801393A1 (ru) 2009-12-30
ME00005B (fr) 2010-06-10
TNSN08272A1 (fr) 2009-10-30
UY30031A1 (es) 2007-07-31
CR10080A (es) 2008-07-10
WO2007072159B1 (fr) 2008-08-21
DOP2006000286A (es) 2007-07-31
JP2009520492A (ja) 2009-05-28
ECSP088551A (es) 2008-07-30
ZA200804780B (en) 2009-05-27
EP1973867A1 (fr) 2008-10-01
NZ568971A (en) 2010-04-30
AR058559A1 (es) 2008-02-13
US20090299093A1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
NO20082989L (no) Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet
AR057467A1 (es) Sales de 4- metil-n-(3-(4-metilimidazol-1-il)-5- trifluorometil- fenil)-3- (4- metil- imidazol-1-il)-5- trifluorometil - fenil)-3-(4- piridin -3- il pirimidin-2- lamino ) - benzamida. metodo de preparacion y composiciones farmaceuticas
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
CY1119624T1 (el) Κρυσταλλικες μορφες του 4-μεθυλο-ν-[3-(4-μεθυλ-ιμιδαζολ-1-υλ)-5-τριφθορομεθυλο-φαινυλο] -3 -(4-πυριδιν-3-υλ-πυριμιδιν-2-υλαμινο)-βενζαμιδιου
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
NO20092652L (no) Konstruert anti-TSLP-antistoff
UA96922C2 (en) Il-12/p40 binding protein
WO2006138343A3 (fr) Compositions comprenant des variants de proteine associee au recepteur (rap) specifiques a lrp2, et utilisations correspondantes
MY163480A (en) Sclerostin binding agents
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
DE602005008996D1 (de) Radiofluorierte peptide
NO20053918L (no) Aminosyrer med affinitet for alfa-2-delta-proteinet.
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
EA200702193A1 (ru) Гликозилирование белков
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
NO20082749L (no) Fremgangsmate for fremstilling av ferri-succinylkasein
WO2007056511A3 (fr) Peptides therapeutiques se liant aux metaux
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
EA200701852A1 (ru) Производные аминокислот
NO20074259L (no) Fremgangsmate for fremstilling av substituerte benzoksazolforbindelser
NO20065643L (no) Fremstilling av beta-aminosyrer som har affinitet for proteinet alfa-2-delta
DK1902033T3 (da) Fremgangsmåde til fremstilling af caboxamider
DK1957463T3 (da) Fremgangsmåde til fremstilling af 5-fluor-1,3-dialkyl-1H-pyrazol-4-carboxylsyrechlorider
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application